R
RTW Investments, LP
+ HältZLAB
-11.31%
3-Monats-Rendite
$23.190
-0.315 (-1.36%)Zum Schluss
Loading chart…
- Hoch
- 24.640
- Eröffnung
- 24.550
- Volumengewichteter Durchschnittskurs
- 23.66
- Volumen
- 843.23K
- Marktkap.
- 1.73B
- Tief
- 23.140
- Umsatz
- 19.95M
- EV/EBITDA, TTM
- -6.03
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
KI-Analyse of Zai Lab Ltd (ZLAB)
HaltenZai Lab Ltd is currently a hold. The stock is priced at $23.19, which is below analysts' targets of $36 and $45, indicating potential upside. However, the RSI is at 35.544, suggesting the stock is nearing oversold territory, yet it has recently declined by 7.20% over the last five days, indicating short-term weakness. The company continues to report negative earnings, with a net income of -51,016,000 USD in Q1 2026 and -50,825,000 USD in Q2 2026, which raises concerns about its profitability. The main risk is the significant insider selling activity, which has increased by 126% over the last month, potentially signaling lack of confidence among insiders.
Analystenbewertungen (3)
+106.68% Aufwärtspotenzial
Kaufen
2 Kaufen
1 Halten
0 Verkaufen
Aktuell: 23.19
Tief
25.70
Durchschnitt
47.93
Hoch
74.00
JPMorgan
Übergewichten
$36
2026-08-27
JPMorgan
2026-08-27
Kursziel
$36
Übergewichten
Citi
Kaufen
$45
2026-08-07
Citi
2026-08-07
Kursziel
$45
Kaufen
Citi
Kaufen
$44
2026-05-08
Citi
2026-05-08
Kursziel
$44
Kaufen
JPMorgan
Übergewichten
$32
2026-03-18
JPMorgan
2026-03-18
Kursziel
$32
Übergewichten
Cantor Fitzgerald
Übergewichten
$37
2026-02-27
Cantor Fitzgerald
2026-02-27
Kursziel
$37
Übergewichten
Bewertungskennzahlen
Das aktuelle erwartete KGV von Zai Lab Ltd (ZLAB) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von -16.19.
Whales, die ZLAB halten
Event-Zeitleiste
News
9.010-14NewsfilterZai Lab to Present ZL-1503 Clinical Trial Data at ACAAI 2026
9.509-17CNBCChinese AI Companies Struggle with Revenue Growth
- 8.509-17Newsfilter
Chinese AI Models Generate Only 10% of Revenue Compared to U.S. Rivals
8.509-14CNBCZ.ai Plans to Raise $5 Billion Through Share Placement and Bonds
- 8.509-14Newsfilter
Z.ai Plans $5 Billion Fundraising, Shares Plunge Over 10%
ZLAB FAQ – beantwortet von Alphio AI
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).
Zai Lab Ltd is currently a hold. The stock is priced at $23.19, which is below analysts' targets of $36 and $45, indicating potential upside. However, the RSI is at 35.544, suggesting the stock is nearing oversold territory, yet it has recently declined by 7.20% over the last five days, indicating short-term weakness. The company continues to report negative earnings, with a net income of -51,016,000 USD in Q1 2026 and -50,825,000 USD in Q2 2026, which raises concerns about its profitability. The main risk is the significant insider selling activity, which has increased by 126% over the last month, potentially signaling lack of confidence among insiders.
3 analysts cover ZLAB: 2 rate it Buy, 1 Hold and 0 Sell. The average price target is 47.93.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.